1 / 6

Heparin Market Overview by Growth Opportunities and Forecast over 2020-2026

Heparin Market Overview by Growth Opportunities and Forecast over 2020-2026

vinayakshinde
Download Presentation

Heparin Market Overview by Growth Opportunities and Forecast over 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Heparin Market Overview by Growth Opportunities and Trends Forecast over 2020-2026 • Global heparin industry trends will be prominently driven by the inclining demand for anticoagulant products that are used to treat venous thromboembolism and coronary artery ailments. The Center for Disease Control and Prevention (CDC), revealed that over 18.2 million adults were diagnosed with coronary artery diseases in 2017 were aged above 20 years. • This factor is likely to stir the adoption of anticoagulant in the coming years. Furthermore, several initiatives and programs have been formulated by the National Institutes of Health (NIH) and CDC to mount the awareness related to the prevention of thrombosis-associated complications in the initial stages across the U.S. As per reports, the global heparin market size will surpass an annual estimation of close to USD 6.6 billion by 2026. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Low molecular weight heparin segment recorded more than USD 3.6 billion in global revenue in 2019, slated for an exponential growth rate through the coming years. This is owing to the rise in heparin use in surgeries as well as in the treatment of coagulation diseases. Researchers experimenting at the Rensselaer Polytechnic Institute and the University of North Carolina (UNC) have come up with a synthetic, low molecular weight heparin structure that is safe to use. • Porcine sourced heparin segment contributed to over 98.8% of the overall share in 2019 as it extensively helps in the prevention of blood clots post-surgery, in dialysis and blood transfusion as well as during the collection of the blood samples. The demand can be further attributed to the higher adoption of the porcine based product in patients affected with atrial fibrillation. • Additionally, the portable air humidifiers segment from the USB-powered humidifiers product line is projected to observApplication of heparin in coronary artery diseases was valued at USD 1 billion in 2019 and is pegged to rise over the coming years owing to the consistent prevalence of the disorder in emerging countries. Recurring cases of arterial thrombosis that are caused by damaged arteries may lead to a rise in myocardial infarction and coronary artery issues. This trend is likely to influence the demand for heparin doses.e massive deployment across residential buildings, further augmenting the overall market size in the process. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Request for a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/4837 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. Regional Analysis • Asia Pacific heparin industry share will gain significant traction through 2026 due to the prominent presence of local manufacturers across the southeast region, besides the existence of a large patient population in India and China that is vulnerable to chronic ailments. As per reports, venous thromboembolism (VTE) emerged as among the most common ailments affecting Asians in 2017, while the incidence rate of the disorder yearly valued at nearly 100 for every 100,000 in the total population. • Competitive Analysis • The competitive landscape of global heparin market is inclusive of players such as Sanofi, Laboratories FarmaceuticosRovi SA, Amphastar Pharmaceuticals Inc, Pfizer, Leo Pharma, Hepalink Group, Changzhou Qianhong Biopharma, Yantai Dongcheng Biochemicals Co., Ltd., Nanjing King-Friend Biochemical Pharmaceutical, Fresenius Kabi © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Latest Research Report On Heparin Market @ https://www.gminsights.com/industry-analysis/heparin-market Request for sample of this research report@ https://www.gminsights.com/request-sample/detail/4837 Request for customization @ https://www.gminsights.com/roc/4837 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com www.gminsights.com

More Related